Solicitation of Nominations for Appointment to the Healthcare Infection Control Practices Advisory Committee, 26151-26152 [2024-07851]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
the 5th Open Government NAP midterm self-assessment report:
• Assessment Clarity and
Comprehensiveness: Feedback on the
clarity and thoroughness of the report
itself in presenting the progress and
challenges encountered during both the
co-creation process and the
implementation process.
• Insights and Learning: Observations
on the lessons and insights derived from
the self-assessment process, including
any areas that may benefit from deeper
analysis.
• Engagement and Inclusivity: Views
of the effectiveness of stakeholder
engagement efforts (including
suggestions for enhancing inclusivity)
during the initial co-creation and the
implementation processes since the
GSA Open Government Secretariat was
stood up in the summer of 2023.
• Utility and Application:
Recommendations on how the Lessons
and Insights of the report can be better
used to inform the remaining
implementation phase and future Open
Government Action Plans.
Resources
Open Government Partnership (OGP)
Independent Review Mechanism (IRM)
Self-Assessment Guidance at https://
www.opengovpartnership.org/wpcontent/uploads/2001/01/OGP_self_
assessment_cal%20FINAL.pdf.
Krystal J. Brumfield,
Associate Administrator, Office of
Government-wide Policy, General Services
Administration.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–OH–22–002,
NIOSH Centers for Agricultural Safety and
Health.
Date: May 23, 2024.
Time: 1 p.m.–5 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Marilyn
Ridenour, B.S.N., M.P.H., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational Safety
and Health, Centers for Disease Control and
Prevention, 1095 Willowdale Road,
Morgantown, West Virginia 26505.
Telephone: (304) 285–5879; Email:
MRidenour@cdc.gov.
The Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the authority
to sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07850 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–07900 Filed 4–11–24; 4:15 pm]
Centers for Disease Control and
Prevention
BILLING CODE 6820–UA–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Healthcare
Infection Control Practices Advisory
Committee
Centers for Disease Control and
Prevention
AGENCY:
Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Healthcare
Infection Control Practices Advisory
Committee (HICPAC). HICPAC consists
of 14 experts in fields including, but not
limited to, infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical and environmental
microbiology, surgery, hospitalist
medicine, internal medicine,
epidemiology, health policy, health
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
26151
services research, public health, and
related fields.
DATES: Nominations for membership on
HICPAC must be received no later than
September 30, 2024. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
emailed to hicpac@cdc.gov; mailed to
HICPAC, Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027; or faxed to (404) 639–4043.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Healthcare
Infection Control Practices Advisory
Committee, Division of Healthcare
Quality Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027. Telephone: (404) 718–
8039; email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are sought for individuals
who have the expertise and
qualifications necessary to contribute to
the accomplishment of the objectives of
the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). Nominees will be selected
based on expertise in the fields of
infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical and environmental
microbiology, surgery, internal
medicine, occupational health, and
public health. Federal employees will
not be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
HICPAC objectives (https://
www.cdc.gov/hicpac/).
Department of Health and Human
Services (HHS) policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
E:\FR\FM\15APN1.SGM
15APN1
26152
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. The Centers for Disease Control
and Prevention (CDC) reviews potential
candidates for HICPAC membership
each year and provides a slate of
nominees for consideration to the
Secretary of HHS for final selection.
HHS notifies selected candidates of
their appointment near the start of the
term in July 2025, or as soon as the HHS
selection process is completed. Note
that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC,
National Institutes of Health, Food and
Drug Administration).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07851 Filed 4–12–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
meeting is open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcomed to listen to the meeting by
joining the teleconference (information
below). The audio conference line has
150 ports for callers.
DATES: The meeting will be held on June
26, 2024, from 11 a.m. to 1 p.m., EDT.
Written comments must be received on
or before June 19, 2024.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
24, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for
Occupational Safety & Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, telephone (513)
533–6800, toll free 1(800) 232–4636,
email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
14109 on March 22, 2024. Unless
continued by the President the Board
will terminate on September 30, 2025,
consistent with E.O. 14109 of September
29, 2023.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy (DOE) facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on the
following: 1. Update on Cybersecurity
Modernization Initiative; 2. Special
Exposure Cohort (SEC) Status Update; 3.
Updates from Workgroups and
Subcommittees 4. Plans for the August
2024 Board Meeting. Agenda items are
subject to change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 89, Number 73 (Monday, April 15, 2024)]
[Notices]
[Pages 26151-26152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07851]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Healthcare
Infection Control Practices Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the Healthcare Infection Control Practices Advisory
Committee (HICPAC). HICPAC consists of 14 experts in fields including,
but not limited to, infectious diseases, infection prevention,
healthcare epidemiology, nursing, clinical and environmental
microbiology, surgery, hospitalist medicine, internal medicine,
epidemiology, health policy, health services research, public health,
and related fields.
DATES: Nominations for membership on HICPAC must be received no later
than September 30, 2024. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to [email protected]; mailed
to HICPAC, Division of Healthcare Quality Promotion, National Center
for Emerging and Zoonotic Infectious Diseases, Centers for Disease
Control and Prevention, l600 Clifton Road NE, Mailstop H16-3, Atlanta,
Georgia 30329-4027; or faxed to (404) 639-4043.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Healthcare
Infection Control Practices Advisory Committee, Division of Healthcare
Quality Promotion, National Center for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control and Prevention, l600 Clifton Road
NE, Mailstop H16-3, Atlanta, Georgia 30329-4027. Telephone: (404) 718-
8039; email: [email protected].
SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who
have the expertise and qualifications necessary to contribute to the
accomplishment of the objectives of the Healthcare Infection Control
Practices Advisory Committee (HICPAC). Nominees will be selected based
on expertise in the fields of infectious diseases, infection
prevention, healthcare epidemiology, nursing, clinical and
environmental microbiology, surgery, internal medicine, occupational
health, and public health. Federal employees will not be considered for
membership. Members may be invited to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of HICPAC objectives (https://www.cdc.gov/hicpac/).
Department of Health and Human Services (HHS) policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on Federal workgroups or prior experience serving
on a Federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple
[[Page 26152]]
committee memberships. Committee members are Special Government
Employees, requiring the filing of financial disclosure reports at the
beginning of and annually during their terms. The Centers for Disease
Control and Prevention (CDC) reviews potential candidates for HICPAC
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2025, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year.
Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, Food and Drug Administration).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-07851 Filed 4-12-24; 8:45 am]
BILLING CODE 4163-18-P
